Webinar Date/Time: Thursday, June 1, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CES
Join this webinar to learn how Syft Tracer, the latest advancement of real-time, trace gas analysis by SIFT-MS, can revolutionize productivity for volatiles analyses. Hear how the recent product innovations unlock analytical bottlenecks and enable faster decision making in critical process steps.
Register Free: https://www.chromatographyonline.com/lcgc_w/sift-ms
Event Overview:
SIFT-MS is a direct-injection mass spectrometry technique that enables seamless "mix-and-match" analysis of volatiles of any functionality, using one stable instrument configuration. This chromatography-free approach provides sensitive and selective high-throughput, multi-component analysis with minimal sample prep and no derivatization. SIFT-MS is also easier to use than chromatographic systems, while delivering faster results through extended calibration stability and greatly reduced method set-up.
This webinar demonstrates how the new, automated Syft TracerTM SIFT-MS platform provides a comprehensive solution to workflow challenges and can replace multiple chromatographic systems. The webinar demonstrates best-practice headspace-SIFT-MS analysis of:
Join us to learn how SIFT-MS is simply faster.
Key Learning Objectives:
Learn how Syft Tracer solves the most difficult analytical challenges while supporting high-throughput environments where 24/7 operation is the standard.
Who Should Attend:
Speakers:
Mark Perkins, Ph.D.
Senior Applications Chemist & SIFT-MS Specialist
Element Materials Technology Laboratory Instrumentation UK Ltd.
Dr. Mark Perkins is a senior applications chemist at Element Materials Technology Laboratory Instrumentation in Cambridge, United Kingdom (formerly Anatune), and a global authority in automated SIFT-MS. Mark has extensive experience in both conventional chromatographic methods as well as SIFT-MS. Prior to joining Anatune in 2015, he spent 12 years as a senior analyst and chromatography section manager at the Malaysian Rubber Board’s UK research center working on regulated pharmaceutical applications within a GMP environment.
Vaughan Langford, PhD
Principal Scientist
Syft Technologies, New Zealand
Vaughan Langford joined Syft Technologies in 2002 after completing his PhD in Physical Chemistry at the University of Canterbury, and post-doctoral fellowships at the Universities of Geneva, Western Australia, and Canterbury. With an extensive background in diverse applications of SIFT-MS, and over 30 peer-reviewed publications, he provides advanced applications support to SIFT-MS users globally.
Leslie Silva, PhD
Applications Scientist
Syft Technologies, United States
Dr. Leslie Silva graduated from the University of Calgary with a PhD in Biochemistry and Molecular Biology prior to a postdoctoral fellowship at MD Anderson Cancer Center and working as a Senior Research Scientist at Lawrence Berkeley National Laboratory. She led an Analytical Chemistry lab for a Food and Beverage startup in San Francisco for four years before joining the Syft Technologies USA team in October of 2020 as an Applications Scientist. Leslie works closely with both the New Zealand the US-based sales and product development team to develop applications and help customers with their SIFT-MS workflows.
Register Free: https://www.chromatographyonline.com/lcgc_w/sift-ms
RAFA 2024 Highlights: Contemporary Food Contamination Analysis Using Chromatography
November 18th 2024A series of lectures focusing on emerging analytical techniques used to analyse food contamination took place on Wednesday 6 November 2024 at RAFA 2024 in Prague, Czech Republic. The session included new approaches for analysing per- and polyfluoroalkyl substances (PFAS), polychlorinated alkanes (PCAS), Mineral Oil Hydrocarbons (MOH), and short- and medium-chain chlorinated paraffins (SCCPs and MCCPs).
Advancing Bladder Cancer Research with Mass Spectrometry: A FeMS Interview with Marta Relvas-Santos
November 12th 2024LCGC International interviewed FeMS Empowerment Award winner Marta Relvas-Santos on her use of mass spectrometry to identify potential biomarkers and therapies for bladder cancer. She also shared insights on her work with FeMS and advice for fellow scientists.